Knowledge Library
Cell and Gene Therapy Testing at WuXi Advanced Therapies
Cell and gene therapies require extensive safety testing all the way from raw materials to commercial lot release. The inherent variability of biologics, small sample sizes and the need for rapid turn- around times all add to the complexity of the testing environment. Learn more about our cell and gene therapy testing offerings.
OXGENE’s AAV and Lentiviral packaging plasmids are now available off-the-shelf at GMP grade globally
Innovative closed process CAR-T cell therapy platform to streamline approach for manufacturing with great predictability
– The development of innovative advanced therapies represents a great opportunity to dramatically improve patients’ lives. However, the rapid and efficient production of these advanced therapies remains a considerable challenge. – Recent technological advancements in the process development of CAR-T cell therapy manufacturing. – A modular approach was used to optimize unit operations to build …Read More >
Phacilitate poster 2 – Downstream development challenges and progress for AAVs
From clarification to separation of empty and full capsids, each downstream processing step has its challenges in viral vector manufacturing at a CDMO.
Phacilitate poster 1 – Accelerating development and manufacturing platform for viral vector
In this poster, we will discuss our recent technical advancement on efficient viral vector manufacturing process development.